1 results
23/Feb/2022
DOI: 10.31744/einstein_journal/2022RB5954
ABSTRACT Despite advances in understanding of carcinogenesis and of treatment of acute myeloid leukemia, this neoplasm still has a lethality of at least 30%. The search for biomarkers that can predict the response to treatment in the early stages of the disease is still necessary. In recent years, a new form of cellular communication between tumor and non-neoplastic cells has been discovered: the exchange of information through extracellular vesicles. These are small vesicles released by membrane-coated cells that carry proteins, […]
Keywords: Biomarkers; Exosomes; Immunomodulation; Leukemia, myeloid, acute; MicroRNAs